Back

Mildly decreased egfr modifies the association between uric acid and risk of kidney function decline: a 5-year population-based cohort study

2 September 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Hypertension: miscellaneous aspects Prevention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Rongchong Huang

Beijing Friendship Hospital, Capital Medical University, Beijing (China)

7 More presentations in this session

Presentation thumbnail
Impact of appendicular skeletal muscle mass on effect of intensive blood pressure control
Doctor X. Wang (Calgary, CA)
Abstract Slides Video
Presentation thumbnail
Central systolic blood pressure, augmentation index and pulse pressure amplification in pregnancy hypertension and their possible role for earlier detection of preeclampsia
Slides Video
Presentation thumbnail
Application of the 2016 ase-eacvi criteria for the assessment of diastolic function in arterial hypertension
Mrs G. Canciello (Napoly, IT)
Abstract Slides Video
Presentation thumbnail
More hypertensive crises in women than in men in a single emergency department
Doctor E. Strzelczyk (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Higher systolic blood pressure in left not right upper limb is associated with all-cause mortality risk in a community-based population
Doctor F. Fan (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Hypertension: miscellaneous aspects

The Event

Event poster

ESC Congress 2024

2 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Comparative clinical outcomes on renal function and mortality of uricosuric agents versus xanthine oxidase inhibitors in patients with hyperuricemia and cardiovascular risks
thumbnail
Congress Presentation
J-shaped association between serum uric acid levels and chronic kidney disease: a cross-sectional study using large health examination data
thumbnail
Congress Presentation
The effect of a selective urate reabsorption inhibitor dotinurad on uric acid and renal function in patients with hyperuricemia and hypertension.

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources